Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hak Choy

Showing results (31-40 of 140) with videos related to

Pageof 14
Sort By:
Cancer|September 5, 2002
Standards of care for anemia management in oncology: focus on lung carcinomaCorey J Langer, Hak Choy, John A Glaspy, et al.
Neoplasia (New York, N.Y.)|May 31, 2007
SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factorM Aktar Ali, Hak Choy, Amyn A Habib, et al.
Frontiers of Radiation Therapy and Oncology|June 1, 2011
Stereotactic body radiation therapy for thoracic cancers: recommendations for patient selection, setup and therapyRobert Timmerman, John Heinzerling, Ramzi Abdulrahman, et al.
Cancer Research and Treatment|July 18, 2012
Personalized Combined Modality Therapy for Locally Advanced Non-small Cell Lung CancerD Nathan Kim, Taek-Keun Nam, Kevin S Choe, et al.
BMC Cancer|December 19, 2014
Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution studyNathan A Cannon, Puneeth Iyengar, Hak Choy, et al.
Seminars in Oncology|July 1, 2005
Prophylactic cranial irradiation with combined modality therapy for patients with locally advanced non-small cell lung cancerL Chinsoo Cho, Jonathan E Dowell, Dan Garwood, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 7, 2002
Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cellsJae Sung Kim, George P Amorino, Hongryull Pyo, et al.
International Journal of Particle Therapy|April 26, 2016
International Symposium on Ion Therapy: Planning the First Hospital-Based Heavy Ion Therapy Center in the United StatesAaron Laine, Arnold Pompos, Michael Story, et al.
Oncology Reports|December 21, 2012
Effect of PF-02341066 and radiation on non-small cell lung cancer cellsVasu Tumati, Subashri Kumar, Lan Yu, et al.
Cancer Research|February 3, 2006
The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cellsPartha Mukhopadhyay, M Aktar Ali, Animesh Nandi, et al.
Pageof 14

Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
Cancer|September 5, 2002
Standards of care for anemia management in oncology: focus on lung carcinomaCorey J Langer, Hak Choy, John A Glaspy, et al.
Neoplasia (New York, N.Y.)|May 31, 2007
SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factorM Aktar Ali, Hak Choy, Amyn A Habib, et al.
Frontiers of Radiation Therapy and Oncology|June 1, 2011
Stereotactic body radiation therapy for thoracic cancers: recommendations for patient selection, setup and therapyRobert Timmerman, John Heinzerling, Ramzi Abdulrahman, et al.
Cancer Research and Treatment|July 18, 2012
Personalized Combined Modality Therapy for Locally Advanced Non-small Cell Lung CancerD Nathan Kim, Taek-Keun Nam, Kevin S Choe, et al.
BMC Cancer|December 19, 2014
Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution studyNathan A Cannon, Puneeth Iyengar, Hak Choy, et al.
Seminars in Oncology|July 1, 2005
Prophylactic cranial irradiation with combined modality therapy for patients with locally advanced non-small cell lung cancerL Chinsoo Cho, Jonathan E Dowell, Dan Garwood, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 7, 2002
Radiation enhancement by the combined use of topoisomerase I inhibitors, RFS-2000 or CPT-11, and topoisomerase II inhibitor etoposide in human lung cancer cellsJae Sung Kim, George P Amorino, Hongryull Pyo, et al.
International Journal of Particle Therapy|April 26, 2016
International Symposium on Ion Therapy: Planning the First Hospital-Based Heavy Ion Therapy Center in the United StatesAaron Laine, Arnold Pompos, Michael Story, et al.
Oncology Reports|December 21, 2012
Effect of PF-02341066 and radiation on non-small cell lung cancer cellsVasu Tumati, Subashri Kumar, Lan Yu, et al.
Cancer Research|February 3, 2006
The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cellsPartha Mukhopadhyay, M Aktar Ali, Animesh Nandi, et al.
Pageof 14